S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

IPA ImmunoPrecise Antibodies Ltd

0.8215

-0.0385 (-4.48%)

Last Updated: 02:05:07

Delayed by 15 minutes

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

0000950170-24-087127.txt

ImmunoPrecise Antibodies (NASDAQ:IPA)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more ImmunoPrecise Antibodies Charts.

ImmunoPrecise Antibodies (NASDAQ:IPA)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more ImmunoPrecise Antibodies Charts.

ImmunoPrecise Antibodies Ltd News

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Monday 29 July 2024 (4 hours ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 29 July 2024 (4 hours ago) • Edgar (US Regulatory)

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024
Monday 29 July 2024 (4 hours ago) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 24 July 2024 (6 days ago) • Edgar (US Regulatory)

ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024
Wednesday 24 July 2024 (6 days ago) • Business Wire

ImmunoPrecise annonce un accord de financement avec Yorkville Advisors Global, LP d'un montant en capital global de 3,0 millions USD de débentures convertibles
Wednesday 17 July 2024 (2 weeks ago) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 17 July 2024 (2 weeks ago) • Edgar (US Regulatory)

ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures
Wednesday 17 July 2024 (2 weeks ago) • Business Wire

IPA présentera le 25 juillet 2024 ses résultats financiers et les faits saillants récents de ses activités pour le quatrième trimestre et l'exercice financier 2024
Tuesday 16 July 2024 (2 weeks ago) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 15 July 2024 (2 weeks ago) • Edgar (US Regulatory)

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024
Monday 15 July 2024 (2 weeks ago) • Business Wire

ImmunoPrecise nomme Kristin Taylor au poste de directeur financier
Friday 28 June 2024 (1 month ago) • Business Wire

More ImmunoPrecise Antibodies Ltd News Articles

Australia And New Zealan...

Newcrest Mining

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions